Cargando…

Evaluation of the SARS-CoV-2-IgG response in outpatients by five commercial immunoassays

Commercially available immunoassays have been developed for sensitive and specific detection of antibodies against SARS-CoV-2. While high sensitivity has been reported in hospitalized COVID-19 patients, little is known about the performance of the assays in ambulatory patients. Therefore, we evaluat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wellinghausen, Nele, Voss, Meike, Ivanova, Ralitsa, Deininger, Susanne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	German Medical Science GMS Publishing House 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7498824/ https://www.ncbi.nlm.nih.gov/pubmed/32983837 http://dx.doi.org/10.3205/id000066

Ejemplares similares

SARS-CoV-2-IgG response is different in COVID-19 outpatients and asymptomatic contact persons
por: Wellinghausen, Nele, et al.
Publicado: (2020)

Analysis of COVID-19 convalescent plasma for SARS-CoV-2 IgG using two commercial immunoassays
por: DomBourian, Melkon G., et al.
Publicado: (2020)

Evaluation of a new combined Western and line blot assay (EUROLINE-WB) for diagnosis and species identification of Echinococcus infection in humans
por: Deininger, Susanne, et al.
Publicado: (2019)

Long-Term Longitudinal Evaluation of Six Commercial Immunoassays for the Detection of IgM and IgG Antibodies against SARS CoV-2
por: Nedelcu, Iulia, et al.
Publicado: (2021)

Evaluation of a New Spike (S)-Protein-Based Commercial Immunoassay for the Detection of Anti-SARS-CoV-2 IgG
por: Eberhardt, Kirsten Alexandra, et al.
Publicado: (2021)

Comparison of five commercial anti-SARS-CoV-2 total antibodies and IgG immunoassays after vaccination with BNT162b2 mRNA
por: Danese, Elisa, et al.
Publicado: (2021)

Comparison of Treponema-specific immunoglobulin G (IgG) index with Treponema pallidum particle agglutination (TPPA) index for detection of intrathecal Treponema-specific antibody synthesis for serological diagnosis of neurosyphilis
por: Wellinghausen, Nele, et al.
Publicado: (2023)

Diagnostic performance of commercial IgM and IgG enzyme-linked immunoassays (ELISAs) for diagnosis of Zika virus infection
por: Kikuti, Mariana, et al.
Publicado: (2018)

Immunoassay for quantification of antigen-specific IgG fucosylation
por: Šuštić, Tonći, et al.
Publicado: (2022)

Evaluation of four laboratory-based SARS-CoV-2 IgG antibody immunoassays
por: Tanis, Jorg, et al.
Publicado: (2021)

Development and validation of an enzyme immunoassay for detection and quantification of SARS-CoV-2 salivary IgA and IgG
por: Costantini, Veronica P., et al.
Publicado: (2021)

Serological Detection of SARS-CoV-2 IgG Using Commercially Available Enzyme Immunoassays on Dried Blood Spots Collected from Patients
por: Walker, Gregory J., et al.
Publicado: (2021)

Performance evaluation of two SARS-CoV-2 IgG/IgM rapid tests (Covid-Presto and NG-Test) and one IgG automated immunoassay (Abbott)
por: Charpentier, Charlotte, et al.
Publicado: (2020)

A novel multiplex electrochemiluminescent immunoassay for detection and quantification of anti-SARS-CoV-2 IgG and anti-seasonal endemic human coronavirus IgG
por: Li, Fang Fang, et al.
Publicado: (2022)

Multiplex Microsphere Immunoassays for the Detection of IgM and IgG to Arboviral Diseases
por: Basile, Alison J., et al.
Publicado: (2013)

The real life performance of 7 automated anti-SARS-CoV-2 IgG and IgM/IgA immunoassays
por: Swadźba, Jakub, et al.
Publicado: (2021)

Comprehensive evaluation of eight commercial SARS-CoV-2 IgG assays
por: Hönemann, Mario, et al.
Publicado: (2021)

Assessment of SARS-CoV-2 IgG and IgM antibody detection with a lateral flow immunoassay test
por: Diani, Erica, et al.
Publicado: (2021)

Comparison of three automatic chemiluminescent immunoassays for monitoring dynamic profile of SARS‐CoV‐2 IgG and IgM
por: Dou, Xiaowen, et al.
Publicado: (2020)

Distribution characteristics of SARS-CoV-2 IgM/IgG in false-positive results detected by chemiluminescent immunoassay
por: Lei, Yan, et al.
Publicado: (2022)

Validation of dried blood spot sample modifications to two commercially available COVID-19 IgG antibody immunoassays
por: Zava, Theodore T, et al.
Publicado: (2020)

Two SARS-CoV-2 IgG immunoassays comparison and time-course profile of antibodies response
por: Dittadi, Ruggero, et al.
Publicado: (2021)

Preliminary multiplex microarray IgG immunoassay for the diagnosis of toxoplasmosis and rubella
por: Baschirotto, Priscila T, et al.
Publicado: (2017)

Evaluation of Four Commercial IgG- and IgM-specific Enzyme Immunoassays for Detecting Mycoplasma pneumoniae Antibody: Comparison with Particle Agglutination Assay
por: Yoo, Soo Jin, et al.
Publicado: (2007)

Validation of a Point‐of‐Care Quantitative Equine IgG Turbidimetric Immunoassay and Comparison of IgG Concentrations Measured with Radial Immunodiffusion and a Point‐of‐Care IgG ELISA
por: Ujvari, S., et al.
Publicado: (2017)

Clinical Evaluation of Antiphospholipase A2 Receptor IgG4 level and Its IgG4-to-IgG Ratio Based on Quantitative Immunoassays in Idiopathic Membranous Nephropathy
por: Zhang, Yi, et al.
Publicado: (2022)

Limited specificity of commercially available SARS‐CoV‐2 IgG ELISAs in serum samples of African origin
por: Emmerich, Petra, et al.
Publicado: (2021)

Performance Characteristics of Four High-Throughput Immunoassays for Detection of IgG Antibodies against SARS-CoV-2
por: Theel, Elitza S., et al.
Publicado: (2020)

Development of indigenous IgG ELISA for the detection of anti-SARS-CoV-2 IgG
por: Sapkal, Gajanan, et al.
Publicado: (2020)

Comparison of enzyme-linked immunosorbent assay and Fassisi(®) bovine immunoglobulin G (IgG) immunoassay for quantification of bovine IgG in neonatal calf serum
por: Hampe, Marian, et al.
Publicado: (2021)

Comparison of a rapid immunochromatographic test with a chemiluminescence immunoassay for detection of anti-SARS-CoV-2 IgM and IgG
por: Gambino, Caterina Maria, et al.
Publicado: (2020)

A Microflow Cytometry-Based Agglutination Immunoassay for Point-of-Care Quantitative Detection of SARS-CoV-2 IgM and IgG
por: Qu, Jianxi, et al.
Publicado: (2021)

Comparison of four new commercial serologic assays for determination of SARS-CoV-2 IgG
por: Krüttgen, Alexander, et al.
Publicado: (2020)

Subclasses of allergen-specific IgG: Serum IgG2 and IgG3 levels are not predicted by IgG1/IgG4 levels
por: MacGlashan, Donald, et al.
Publicado: (2021)

Diagnostic performance of an automated chemiluminescence immunoassay for SARS-CoV-2 IgG and IgM antibodies detection: A real life experience
por: Villalta, Danilo, et al.
Publicado: (2021)

Technical performance of a lateral flow immunoassay for detection of anti-SARS-CoV-2 IgG in the outpatient follow-up of non-severe cases and at different times after vaccination: comparison with enzyme and chemiluminescent immunoassays
por: Barreira, Gabriel Acca, et al.
Publicado: (2022)

Performance evaluation of five ELISA kits for detecting anti-SARS-COV-2 IgG antibodies
por: Yassine, Hadi M., et al.
Publicado: (2021)

Side-By-Side Evaluation of Three Commercial ELISAs for the Quantification of SARS-CoV-2 IgG Antibodies
por: Girl, Philipp, et al.
Publicado: (2022)

Enzyme immunoassays (EIA) for serodiagnosis of human leptospirosis: specific IgG3/IgG1 isotyping may further inform diagnosis of acute disease
por: Fortes-Gabriel, Elsa, et al.
Publicado: (2022)

Development of fluorescent lateral flow immunoassay for SARS-CoV-2-specific IgM and IgG based on aggregation-induced emission carbon dots
por: Ju, Jian, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_okkive87ldolmdkjkbhn799m7t